a developer of cancer therapies that harness the growing understanding of the molecular blueprint of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with BBIO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then BBIO could also see price increases.
Ticker / NAME | Correlation To BPMC | 1D Price Change % | ||
---|---|---|---|---|
BPMC | 100% | +0.27% | ||
BBIO - BPMC | 48% Loosely correlated | +0.69% | ||
BEAM - BPMC | 45% Loosely correlated | -1.57% | ||
SNDX - BPMC | 45% Loosely correlated | +2.59% | ||
DNLI - BPMC | 45% Loosely correlated | -0.87% | ||
KRYS - BPMC | 44% Loosely correlated | -1.60% | ||
More |
Ticker / NAME | Correlation To BPMC | 1D Price Change % |
---|---|---|
BPMC | 100% | +0.27% |
cancer theme (82 stocks) | 64% Loosely correlated | -2.38% |
therapy theme (23 stocks) | 57% Loosely correlated | -3.41% |
drugs theme (254 stocks) | 53% Loosely correlated | -1.72% |
biotechnology theme (238 stocks) | 32% Poorly correlated | -1.80% |